Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Easton Pharmaceuticals Inc EAPH

Healthcare Biotechnology

Easton Pharmaceuticals, Inc. is a development-stage company engaged in various pharmaceutical sectors and others industries. The Company has a transdermal delivery technology (Viorra Delivery Matrix or VDM), which is incorporated in a line of therapeutic over-the-counter (OTC) products. The Company owns topically-delivered drugs and therapeutic/cosmetic healthcare products focused on cancer and... see more

Add To Watchlist

Recent & Breaking News (GREY:EAPH)

Easton Pharmaceuticals and Partner BMV Medica Announces Sales & Distribution Negotiations With Womens Health-Focused Multi-National European Pharma Company

Marketwired April 6, 2016

Easton Pharmaceuticals and Partner BMV Medica Announces Regulatory Filing of Its Patented Women's Health Diagnostic Product, VS-Sense for the Mexico Market, Provides Update on Generic Cancer Drugs, Paclitaxel, Docetaxel

Press Releases February 16, 2016

Easton Pharmaceuticals and BMV Medica Announce Placing Initial Order for Both of Its Patented Women's Health Diagnostic Products for the Mexico Market From Manufacturer, CommonSense Inc.

Marketwired February 1, 2016

Easton Pharmaceuticals Provides Regulatory Filing Update for Its EvaPro (VS-Sense) Women's Diagnostic Product and Provides Updates on the Marketing and Sales of Currently Approved Products for Most Latin American Markets

Marketwired January 6, 2016

Easton Pharmaceuticals Provides Update on Its Canadian Medical Marijuana Initiatives; Cancels 200 Million Common Shares and Reports Its Recent Attendance at the Congress of Obstetrics & Gynecology Was a Huge Success

Marketwired November 17, 2015

Easton Pharmaceuticals Announces It Can Commence Marketing and Sales of Approved Products for Most of Latin American Markets

Marketwired November 3, 2015

Easton Pharmaceuticals Letter to Shareholders and Update

Marketwired October 7, 2015

Easton Pharmaceuticals Announces Finalized Agreement to Secure All of Spanish-Speaking Latin America, Adding to Its Mexico Rights for the VS-Senses Patented Women's Vaginal Health Diagnostic Test

Marketwired September 15, 2015

Easton Pharmaceuticals Closes on First Wholesale Sales Order for Skin Renou HA for Mexico and Other Latin American Countries With BMV Medica

Marketwired August 26, 2015

Easton Pharmaceuticals Announces Major Initiative Supporting Its Focus on Unique Patented Women's Health Products With the Appointment of Dr. Jose Tiran as Founding Member of Easton's Medical/Scientific Advisory Board in Women's Health

Marketwired August 17, 2015

Easton Pharmaceuticals and BMV Medica Finalize License Agreement With CommonSense Ltd. of Israel to Be Sole Distributor for Patented AL-Sense (Amnio-Sense-Blue) Amniotic Fluid Leak Test for Latin America

Marketwired August 4, 2015

Easton Pharmaceuticals and BMV Medica Finalize License Agreement With CommonSense Ltd. of Israel to Be Sole Distributor for Patented AL-Sense (Amnio-Sense-Blue) Amniotic Fluid Leak Test for Latin America

Marketwired August 4, 2015

Easton Pharmaceuticals Announces the Appointment of Evan Karras as CEO / Director and Mr. Nunzio Valerie as President / CFO; Mr. Karras Possesses a Strong Background in Canadian and International Commercial Successes and Is Expected to Make Major Impact on Implementation of Easton's Business Plan

Marketwired July 29, 2015

Easton Pharmaceuticals / BMV Medica Announces Its Mexican Ministry of Health and Latin America Regulatory Filing and Approval Process for Cancer Drugs Paclitaxel and Docetaxel From Biolyse Pharma Has Been Shortened

Marketwired July 6, 2015

Medical marijuana update: Enertopia (C.TOP) bows out, places future hopes on sex gel

Chris Parry June 23, 2015

Booming Cannabis Industry's Need For Quality Control Can Be Solved

Accesswire June 23, 2015

Easton Pharmaceuticals and BMV Medica Announce Eva Pro as Brand Name for Its Line of Patented Women's Diagnostic Tests for the Mexican and Other Latin American Markets; Trademark Registration of Individual Product Names, Logos and Packaging Has Commenced

Marketwired June 23, 2015

Easton Pharmaceuticals and BMV Medica Sign MOU Towards Exclusive Distribution for Woman's Patented Diagnostic Test for Amniotic Fluid Detection for Women in Late Pregnancy for the Majority of Latin American Countries

Marketwired June 18, 2015

Easton Pharmaceuticals Moves to Directly Negotiate Exclusive Agreement With Private Medical Marijuana Grower in Canada as a Result of Galileo Life Science's Actions Toward Its Previously Executed Option and Purchase Agreement; Provides Formal Action Response

Marketwired June 17, 2015

Easton Pharmaceuticals and BMV Medica Close on Joint Distribution Agreement for Injectable Approved Cancer Drugs for Mexico and Other Latin American Countries With Biolyse Pharma Corporation

Marketwired June 15, 2015